Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3

BACKGROUND: The phase III ATTRACTION-3 study showed that second-line nivolumab monotherapy for advanced esophageal squamous cell carcinoma prolonged overall survival (OS) but did not improve progression-free survival (PFS). Subsequent systemic therapy after discontinuing nivolumab may affect these o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Keisho, Yamamoto, Shun, Takahashi, Masanobu, Kadowaki, Shigenori, Kubota, Yutaro, Amanuma, Yusuke, Okada, Morihito, Kanda, Mitsuro, Kimura, Yasue, Nogi, Yuhiko, Arimitsu, Yuko, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024664/
https://www.ncbi.nlm.nih.gov/pubmed/36564602
http://dx.doi.org/10.1007/s10388-022-00972-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024664/
https://www.ncbi.nlm.nih.gov/pubmed/36564602
http://dx.doi.org/10.1007/s10388-022-00972-z

Ejemplares similares